Assessing MedTech impact from potential China tariffs

seekingalpha11-10

J Studios/DigitalVision via Getty ImagesWith President-elect Donald Trump proposing tariffs as high as 60%- 100% on goods imported from China, Wall Street analysts and company CEOs weighed in on how ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2482478168?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2171263147/image_2171263147.jpg?io=getty-c-w750","is_english":true,"pubTime":"2024-11-10 00:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2482478168","market":"sg","top_or_hot":-1,"title":"Assessing MedTech impact from potential China tariffs","media":"seekingalpha","content":"<div>\n<p>J Studios/DigitalVision via Getty ImagesWith President-elect Donald Trump proposing tariffs as high as 60%- 100% on goods imported from China, Wall Street analysts and company CEOs weighed in on how ...</p>\n\n<a href=\"https://seekingalpha.com/news/4269625-assessing-med-tech-impact-from-potential-china-tariffs\">Source Link</a>\n\n</div>\n","source":"seekingalpha_trending_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Assessing MedTech impact from potential China tariffs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAssessing MedTech impact from potential China tariffs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-10 00:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4269625-assessing-med-tech-impact-from-potential-china-tariffs><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>J Studios/DigitalVision via Getty ImagesWith President-elect Donald Trump proposing tariffs as high as 60%- 100% on goods imported from China, Wall Street analysts and company CEOs weighed in on how ...</p>\n\n<a href=\"https://seekingalpha.com/news/4269625-assessing-med-tech-impact-from-potential-china-tariffs\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7049","symbol_name":"互联网与直销零售","start_time":0,"source_url":"https://seekingalpha.com/news/4269625-assessing-med-tech-impact-from-potential-china-tariffs","article_id":"2482478168","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2171263147/image_2171263147.jpg?io=getty-c-w750"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2482478168","pubTimestamp":1731169693,"sourceInfo":{"source_id":"seekingalpha_trending_news","name":"Seeking Alpha Trending News"},"weMediaInfo":null,"summary":"J Studios/DigitalVision via Getty ImagesWith President-elect Donald Trump proposing tariffs as high as 60%- 100% on goods imported from China, Wall Street analysts and company CEOs weighed in on how i","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7049":"互联网与直销零售","MMM.AU":"Marley Spoon","LU0048573561.USD":"FIDELITY AMERICA \"A\" (USD) INC","LU1791807156.HKD":"BGF WORLD FINANCIALS \"A2\" (HKDHDG) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0124676726.USD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (USD) ACC","LU0566484027.USD":"安本美国小盘成长股","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU0130517989.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"R\" INC","GEHC":"GE HEALTHCARE TECHNOLOGIES INC","MASI":"麦斯莫医疗","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","BK4559":"巴菲特持仓","LU0310800965.SGD":"FTIF - Templeton Global Balanced A Acc SGD","BAX":"百特国际","BLCO":"博士伦","LU2361044949.HKD":"WELLINGTON US QUALITY GROWTH \"A\" (HKD) ACC","LU0106831901.USD":"贝莱德世界金融基金A2","BK7501":"新冠治疗股","LU0175139822.USD":"AB FCP I Global Equity Blend A USD","TNDM":"糖尿病保健","NVST":"Envista Holdings","LU2361044865.SGD":"WELLINGTON US QUALITY GROWTH \"A\" (SGDHDG) ACC","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU0689626769.HKD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (HKD) ACC","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","LU0511384066.AUD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (AUDHDG) ACC","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC","STE":"思泰瑞医疗","LU1059921491.USD":"NORDEA 1 GLOBAL STABLE EQUITY \"HB\" (USDHDG) ACC","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","BDX":"碧迪医疗","BK4504":"桥水持仓","MMM":"3M","LU0477156953.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"RE\" (USD) ACC","LU1035773651.USD":"AB SICAV I - GLOBAL VALUE PORTFOLIO \"AD\" (USD) INC","LU0251131958.USD":"FIDELITY AMERICA \"A\" (USD) ACC","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","LU0205193047.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD)  ACC","LU1303367103.USD":"摩根大通多经理另类基金 A (acc)","LU0289739343.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","FMS":"费森尤斯医疗","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","LU0162691827.USD":"BGF US BASIC VALUE \"A4\" INC","SOLV":"Solventum","LU1854103824.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) INC","MMSI":"Merit Medical Systems"},"translate_title":"评估中国潜在关税对医疗技术的影响","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TNDM":1,"STE":1,"SOLV":1,"NVST":1,"MMSI":1,"MMM.AU":1,"BLCO":1,"MMM":1,"MASI":1,"BDX":0.9,"BAX":0.9,"FMS":0.9,"GEHC":0.9},"content_text":"J Studios/DigitalVision via Getty ImagesWith President-elect Donald Trump proposing tariffs as high as 60%- 100% on goods imported from China, Wall Street analysts and company CEOs weighed in on how its potential implementation could impact the MedTech industry. Citing remarks from companies in its MedTech coverage, Wells Fargo analysts led by Larry Biegelsen noted that most had limited to no manufacturing footprint in China, even though their median sales exposure to China stood at ~3% of revenue.  Biegelsen argued that GE HealthCare (NASDAQ:GEHC) and Merit Medical (MMSI) had the highest sales exposure to China at 12% each, while Solventum (SOLV), Envista (NVST), and Bausch + Lomb (BLCO) trailed with 8% each. “Some of the large-cap companies noted their global footprint that reduces overdependency on a single geography,” he wrote. Several MedTech firms echoed similar thoughts this week after issuing their quarterly results following Trump’s successful reelection bid. Company remarks Becton Dickinson (NYSE:BDX) CEO Tom Polen said during the company's Q4 earnings call on Thursday that \"from a China perspective, our strategy has always been strong local manufacturing in China for China.\" \"Our network is set up to serve local markets with heavy local manufacturing in many cases,\" he noted, adding, \"We're a very strong domestic manufacturer in the U.S.\" Joe Almeida, CEO of Baxter International (NYSE:BAX), argued that China accounts for less than 2% of company sales\" and added, \"But we do not specifically make products in China for the U.S.\" 3M (MMM) Spinoff Solventum (SOLV) offered similar views. \"When I think about what we actually bring in from China, it's a relatively small number,\" CEO Bryan Hanson said, noting that the company's China sales make up slightly over 5% of its global business. \"And as a result of that, just given what we know, I really don't see tariffs as being a major impact to our business,\" he added. When asked about potential tariffs, Dan Carestio, CEO of sterilization services provider STERIS (STE), noted that his company's global contract sterilization business has resorted to reshoring and front-shoring to offset any impact. \"We seen we've seen enormous growth in our Asia Pacific region\" over the past two years, Carestio said, adding, \"It's more of a front-shoring operation in anticipation of some challenges that might or may not occur as it relates to China.\" However, there are some concerns in the industry. According to Wells Fargo, pulse oximetry company Masimo (MASI) has a \"meaningful portion\" of its sensor components imported from China. Déjà vu Looking back at company commentary during the implementation of 2018-19 China tariffs under Trump, Wells Fargo said that most firms in its coverage with China exposure had cited a modest impact. Even Mexican tariffs in 2019 had no \"material impact,\" analyst Biegelsen added. BD CEO Polen agreed, noting, \"When we saw this dynamic that happened in the past, we didn't see significant impacts from that.\" Insulin pump maker Tandem Diabetes (TNDM) said the company has made potential tariffs on imports a priority issue.  \"We have a wide supply chain that does cross into some of the Asian countries that could potentially be problematic, CEO John Sheridan noted, adding, but we have the flexibility to move things as we need to.\" \"So, we're definitely thinking about it; it's sort of top-of-mind right now,\" Sheridan said. Too early to panic?  For others, it’s too early to assess any impact from potential tariffs, and Wells Fargo expects that there could be exceptions for certain medical components or products. Despite its reliance on China for sensor materials, Masimo (MASI) has said “it's too early to tell potential tariff impact,” according to Wells Fargo. Michael Sen, CEO of the German dialysis firm Fresenius (NYSE:FMS), agreed. “We have all heard the statements on tariffs and the like,” Sen said during the recent earnings call, adding, “It’s way too premature as to what the agenda of the new president will be.”","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2482478168"}